Paik Kwang Ind (001340) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Paik Kwang Ind stock KRW 3,400, price KRW 4,140, that is 17.9% below the price, quality 40 out of 100. Rating: overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.
How to read this chart
60‑month range 2,920 KRW – 17,557 KRW · fair‑value band 2,541 KRW – 4,719 KRW · the 4,140 KRW price screens above the 3,400 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.
Follow Paik Kwang Ind in your weekly email
Every Wednesday you see whether Paik Kwang Ind is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Paikkwang Industrial Co.,Ltd produces and sells inorganic chemical products in South Korea and internationally. It offers caustic soda, hydrochloric acid, liquid chlorine, sodium hypochlorite, and nitrous oxide, as well as nitrogen trifluoride and hydrogen.
Show moreShow less
It also provides D-sorbitol, maltitol syrup, and polyglycitol syrup, as well as re-inspection and internal treatment of high pressure gas cylinders. The company was formerly known as Paik Kwang Industrial Co. and changed its name to Paikkwang Industrial Co.,Ltd in April 2025.
Paikkwang Industrial Co.,Ltd was founded in 1954 and is headquartered in Gunsan-si, South Korea.
Stock analysis
Paik Kwang Ind (001340) currently trades at 4,140 KRW, while our model-based Fair Value estimate is 3,400 KRW, 18% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 3,879 KRW per share, and 2 of the 14 models we run sit above the 4,140 KRW price.
Bear case: the Dividend Discount group reads lowest at 737.26 KRW, and 12 of the 14 models stay below the price. Data coverage for this calculation is high.
Scenario range: 2,541 KRW (bear) to 4,719 KRW (bull), the price of 4,140 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 40/100 (below-average quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Paik Kwang Ind reported revenue of 272B KRW in FY2025 versus 191B KRW in FY2021, a compound +9.2%/yr. Reported net income was 10.1B KRW in FY2025, compounding −9.3%/yr from FY2021.
Key figures
Market cap 188B KRW (≈ $139M) Micro · P/E ratio 27.9 · P/S ratio 0.67 · EPS (TTM) 169.63 KRW · Dividend yield 0.7% · Net margin 2.7% · Return on equity 3.4% · Return on assets (EBIT) 4.0% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 48% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at −18%, 001340 screens cheaper than that median.
Fair Value models
Bear2,541 KRWFair Value 3,400 KRWBull4,719 KRW
Price 4,140 KRW · Downside -17.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (119.74 KRW per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.34/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+11.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.7%
Start year 2020 (pandemic)
Revenue growth 17 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.0%
’10
’11
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−6.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−7.5%
Dividend (yield on the price)0.7%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 5%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 728 stocks
Beats the industry median on 4/13 measures
Overall it trails its industry peers.
Valuation
Quality Score40 · Bottom 25%
Fair Value upside−17.9% · Above median
Profitability
Return on equity (12 months)3.4% · Below median
Return on assets1.7% · Below median
Net margin (12 months)2.7% · Below median
Operating margin (12 months)7.6% · Below median
Growth and dividend
Revenue growth (quarter YoY)8.1% · Below median
Dividend yield (12 months)0.7% · Below median
Balance sheet
Debt / equity0.43× · Highest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Paik Kwang Ind Fair Value". https://www.fairvalue-calculator.com/stock/001340
Frequently asked questions
Is Paik Kwang Ind (001340) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of 3,400 KRW versus a price of 4,140 KRW, about 18% lower (overvalued).
What is the fair value of 001340?
Our model-based fair value for Paik Kwang Ind is 3,400 KRW (as of Nov 4, 2026), built from audited fundamentals. The current price: 4,140 KRW.
What is the quality score of 001340?
Paik Kwang Ind has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Paik Kwang Ind (001340)?
Our model-based price target is the fair value of 3,400 KRW (as of Nov 4, 2026) from 14 valuation models. Cautious scenario 2,541 KRW, optimistic scenario 4,719 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Paik Kwang Ind stock forecast for 2026?
Our models put fair value at 3,400 KRW, about 18% lower versus a price of 4,140 KRW (overvalued). Cautious scenario 2,541 KRW, optimistic scenario 4,719 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Paik Kwang Ind (001340)?
Paik Kwang Ind reported trailing-twelve-month revenue of about 283B KRW (latest available figure, as of Nov 4, 2026).
Does Paik Kwang Ind pay a dividend?
Paik Kwang Ind currently shows a dividend yield of 0.72% relative to its recent price (as of Nov 4, 2026).
How much is the dividend of Paik Kwang Ind (001340) and when is the ex-dividend date?
Paik Kwang Ind pays a dividend of 30.00 KRW per share a year, a dividend yield of 0.7%. The last ex-dividend date was Dec 29, 2025. The payout ratio is 17.7% of earnings. Our assessment: Token dividend. At a yield of 0.7% the dividend is symbolic. On paper it is not fully covered by earnings or free cash flow, but at this size that hardly matters: even scrapping it entirely would cost less than 0.7% a year, and coverage ratios on amounts this small swing with ordinary working-capital movements. Judge this company on its business, not on its dividend.
What is the intrinsic value of Paik Kwang Ind (001340)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Paik Kwang Ind it is 3,400 KRW per share (as of Nov 4, 2026), against a price of 4,140 KRW. It is the blended result of 14 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Paik Kwang Ind stock overvalued or undervalued in 2026?
As of Nov 4, 2026, 001340 trades above its calculated fair value: price 4,140 KRW, fair value 3,400 KRW, a gap of about −18% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 001340?
No. The price is what the market pays today (4,140 KRW); the fair value is what the company's own numbers justify (3,400 KRW). For Paik Kwang Ind the two are 740.41 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Paik Kwang Ind worth?
The market values Paik Kwang Ind at about 188B KRW (market capitalisation, as of Nov 4, 2026). Per share that is 4,140 KRW; our models calculate a fair value of 3,400 KRW per share.
What do the bullish and bearish scenarios say about 001340?
Our models span a range for Paik Kwang Ind: cautious scenario 2,541 KRW, base 3,400 KRW, optimistic 4,719 KRW per share (as of Nov 4, 2026, price 4,140 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 001340?
Paik Kwang Ind trades at a price-to-earnings ratio of 27.9 (as of Nov 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 3,400 KRW is built from several models across several years. Median P/E at fiscal year-end, 8 fiscal years (2017 to 2025), reported earnings, FY2025 ex one-offs: 14.9. Other multiples: P/B 0.8, P/S 0.7, EV/EBITDA 6.5.
How solid is the balance sheet of Paik Kwang Ind (001340)?
Balance-sheet figures for Paik Kwang Ind (as of Nov 4, 2026): return on equity 3.4%, debt of 0.43 per unit of equity. They feed the Quality Score of 40/100, which measures business quality independently of the share price.
How far is 001340 from its 52-week high?
Paik Kwang Ind trades at 4,140 KRW, about 48% below its 52-week high of 7,970 KRW and at the low of 4,140 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 3,400 KRW is for.
Which stocks are comparable to Paik Kwang Ind?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Paik Kwang Ind stock attractive at the current price?
The data as of Nov 4, 2026: price 4,140 KRW, calculated fair value 3,400 KRW (−18%), Quality Score 40/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 001340 calculated?
We run Paik Kwang Ind through 14 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 3,400 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Paik Kwang Ind itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Paik Kwang Ind (001340)?
The closing price on Nov 6, 2026 was 4,140 KRW. Our model-based fair value is 3,400 KRW, about 18% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Paik Kwang Ind right now?
Weak quality (40/100) and above fair value at the same time, the margin of safety is missing on both counts. A fairly wide model range (2,541 KRW to 4,719 KRW) leaves room in how you read the outcome.
Key figures of Paik Kwang Ind
How large is the market capitalisation of Paik Kwang Ind (001340)?
The market capitalisation of Paik Kwang Ind is 188B KRW (≈ $139M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Paik Kwang Ind (001340)?
The price-to-sales ratio of Paik Kwang Ind is 0.67 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Paik Kwang Ind (001340)?
Earnings per share at Paik Kwang Ind are 169.63 KRW (price ÷ EPS = P/E 27.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Paik Kwang Ind (001340)?
The dividend yield of Paik Kwang Ind is 0.7% (payout 17.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Paik Kwang Ind (001340)?
The net margin of Paik Kwang Ind is 2.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Paik Kwang Ind (001340)?
The return on equity (ROE) of Paik Kwang Ind is 3.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Paik Kwang Ind (001340)?
On an EBIT basis the return on assets of Paik Kwang Ind is 4.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Paik Kwang Ind (001340)?
The operating margin of Paik Kwang Ind is 7.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Paik Kwang Ind (001340)?
Revenue at Paik Kwang Ind is growing +8.1% versus a year earlier (3y avg +5.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Paik Kwang Ind (001340)?
Earnings per share at Paik Kwang Ind are growing +78.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Paik Kwang Ind (001340) generate?
The free cash flow of Paik Kwang Ind is −117B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Paik Kwang Ind (001340) carry?
The net debt of Paik Kwang Ind is 256B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Paik Kwang Ind in the live analysis
One click puts Paik Kwang Ind on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 4, 2026